CanadaBis Capital Inc
XTSX:CANB
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
C
|
CanadaBis Capital Inc
XTSX:CANB
|
3.5m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
293B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.5B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.4B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.9B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
CanadaBis Capital Inc
Glance View
CanadaBis Capital Inc. is a capital pool company, which engages in the identification and evaluation of assets or a business. The company is headquartered in Rocky Mountain House, Alberta. The company went IPO on 2017-03-08. The Company’s segments include Wholesale, Retail, and Extraction and Tolling. The Wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards that are subsequently sold to end consumers. The Retail segment involves in the sale of cannabis and cannabis-related products to end consumers on premise owned and operated by the Company. The Extraction and Tolling segment provides cannabinoid extraction services to other licensed producers. The Company’s subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd, Full Spectrum Labs Ltd, 2103157 Alberta Ltd. and Goldstream Cannabis Inc.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for CanadaBis Capital Inc is 45.5%, which is below its 3-year median of 49.3%.
Over the last 3 years, CanadaBis Capital Inc’s Gross Margin has decreased from 47.3% to 45.5%. During this period, it reached a low of 44.4% on Jul 31, 2025 and a high of 55.4% on Apr 30, 2024.
